An error appeared in the 1 September issue of the Journal [Gnann JW, Sköldenberg B, Hart J, et al. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis 2015; 61:683–91]. In the Methods section, the last sentence of the first paragraph should read “Patients were randomized to either 6 g of VACV daily (administered as four 500-mg tablets 3 times daily) or identical placebo tablets for 90 days,” [not 2 g of VACV daily].
The authors regret this error.